discontinuing b lactam treatment after 3 days for patients with cap - juan camilo jaramillo
Published 3 years ago • 421 plays • Length 56:53Download video MP4
Download video MP3
Similar videos
-
3:33
sellar germinoma, lung metastasis - endoscopic biopsy to confirm and refer patient for irradiation
-
2:47
a study comparing br to ibrutinib in the frontline treatment of waldenström's macroglobulinemia
-
1:14
phase i study of abbv-383, a bcma×cd3 bispecific antibody, in r/r myeloma
-
1:16
dll3/cd3 bispecific antibody: mechanism of action
-
3:04
treatment options for patients with lbcl who relapse or are refractory to initial treatment
-
1:37
causes & management of ibrutinib discontinuation in cll
-
2:29
combining menin/flt3/bcl2 inhibition as a treatment approach in flt3/npm1 double mutated aml
-
1:39
an update on the gimema lal2317 trial: sequential chemotherapy blinatumomab for ph-like all
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
0:48
integrating data to improve cbcl diagnosis
-
2:30
team conditioning prior to auto-hsct in lymphoma: replacing the b in beam?
-
3:36
ukall14: rituximab dose & reduced intensity transplant in b-all & nelarabine consolidation in t-all
-
1:35
maintenance & consolidation strategies for all and their impact on qol
-
1:05
long-term outcomes of patients with cll treated with continuous ibrutinib
-
1:22
diagnostics and treatment outcomes from primary cbcl